Agrace Expands Hospice Services Through New Partnership
Agrace's Commitment to Quality Care
Agrace, recognized as Wisconsin's largest nonprofit hospice, is proud to announce its collaboration with Crossing Rivers Health. This partnership marks a significant step towards enhancing the local community's end-of-life care services.
Strategic Partnership with Crossing Rivers Health
In this new chapter, Agrace is set to take over the hospice program from Crossing Rivers Health, which has opted to concentrate its efforts on core healthcare services. As part of this transition, patients currently in the Crossing Rivers Health hospice program will have the opportunity to move to Agrace's level of care by the end of September.
A Vision for the Future
Lynne Sexten, Agrace President & CEO, expressed her enthusiasm about this partnership. "We are honored to be appointed as the Preferred Hospice Partner by Crossing Rivers Health. This agreement showcases our commitment to quality care and support in the community," she stated. Agrace continues to expand its reach by ensuring high-quality, compassionate hospice services are accessible throughout the upper Midwest.
History of Compassionate Care
Since its establishment in 1978, Agrace Hospice Care has been dedicated to providing exceptional end-of-life care to patients of all ages across southern Wisconsin. This dedication means that residents of the region can expect personalized hospice services wherever they reside, affirming Agrace's mission to serve with dignity and respect.
About Agrace
Agrace is more than just a healthcare provider; it is a community-supported organization that prioritizes the needs of patients who are aging, seriously ill, or grieving. With multiple locations spread across Wisconsin, including Madison, Wauwatosa, Oconomowoc, Janesville, Baraboo, Dodgeville, and La Crosse, Agrace serves over 1,700 patients daily, emphasizing its role in providing compassionate hospice care.
Connecting with Agrace
Individuals interested in learning more about Agrace's services are encouraged to reach out. They can contact the organization directly at (608) 276-4660 to engage with their team, who are always ready to provide guidance and support.
Frequently Asked Questions
What is Agrace's new partnership about?
Agrace has partnered with Crossing Rivers Health to take over its hospice program, aiming to enhance end-of-life care.
How will this change affect current patients?
Current Crossing Rivers Health hospice patients will have the option to transition to Agrace’s care by the end of September.
What are the goals of Agrace's partnership?
The partnership aims to provide high-quality, nonprofit hospice care to the community, ensuring comfort and support for patients and families.
When was Agrace founded?
Agrace was founded in 1978 and has since been dedicated to offering compassionate end-of-life care across Wisconsin.
How can I contact Agrace?
Interested individuals can reach Agrace at (608) 276-4660 for more information about their services.
About The Author
Contact Thomas Cooper privately here. Or send an email with ATTN: Thomas Cooper as the subject to contact@investorshangout.com.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.
